TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12585579

Group type: EXPERIMENTAL
Intervention: Mobile-bearing total knee prosthesis
Number of subjects: 2

Group type: COMPARATOR
Intervention: Fixed-bearing total knee prosthesis
Number of subjects: 2
Study: 10190881

Group type: EXPERIMENTAL
Intervention: Short-term hypoxic breathing at low altitude
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-altitude exposure (4559 m)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sympathetic nerve activity
Number of subjects: 15
Study: 7762844

Group type: EXPERIMENTAL
Intervention: IA bupivacaine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac and IA bupivacaine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: IA bupivacaine with ketorolac
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: IA ketorolac
Number of subjects: 4
Study: 2111093

Group type: EXPERIMENTAL
Intervention: Penicillin V
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cefaclor
Number of subjects: 150
Study: 637709

Group type: EXPERIMENTAL
Intervention: Albumin (25 gm initially, then 150 gm/day for 3-5 days)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No albumin (Control group)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 52
Study: 31637603

Group type: EXPERIMENTAL
Intervention: Robotic proctectomy (RP)
Number of subjects: 8107
Study: 29998336

Group type: EXPERIMENTAL
Intervention: Immediate monitoring with a home-based wearable ECG patch
Number of subjects: 2659

Group type: COMPARATOR
Intervention: Delayed monitoring with a home-based wearable ECG patch
Number of subjects: 2659

Group type: EXPERIMENTAL
Intervention: Combined actively monitored groups
Number of subjects: 2659

Group type: COMPARATOR
Intervention: Matched observational controls
Number of subjects: 2659

Group type: EXPERIMENTAL
Intervention: Active monitoring
Number of subjects: 2659
Study: 27684308

Group type: EXPERIMENTAL
Intervention: Linagliptin/metformin
Number of subjects: 245

Group type: COMPARATOR
Intervention: Linagliptin
Number of subjects: 245
Study: 24608948

Group type: EXPERIMENTAL
Intervention: Grain sorghum muffin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Whole-wheat flour muffin (control)
Number of subjects: 10
Study: 22263674

Group type: COMPARATOR
Intervention: rosuvastatin 10 mg + fenofibric acid 135 mg
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg + fenofibric acid 135 mg
Number of subjects: 261
Study: 22166525

Group type: EXPERIMENTAL
Intervention: Epirubicin (EPI) 30 mg/30 ml, 29 doses over 24 months
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Pirarubicin (THP) 30 mg/30 ml, 29 doses over 24 months
Number of subjects: 189

Group type: COMPARATOR
Intervention: Hydroxycamptothecin (HCPT) 30 mg/30 ml, 29 doses over 24 months
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: EPI and THP
Number of subjects: 189
Study: 17635177

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (92 controls from transversal study)
Number of subjects: 144
Study: 16135725

Group type: EXPERIMENTAL
Intervention: Montelukast (40 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12404696

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 10645355

Group type: EXPERIMENTAL
Intervention: Early non-weightbearing ankle mobilisation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ankle immobilisation
Number of subjects: 52
Study: 7593479

Group type: EXPERIMENTAL
Intervention: fenfluramine and scopolamine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: behavioral activation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: scopolamine
Number of subjects: 11

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: fenfluramine
Number of subjects: 11
Study: 1951336

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Diltiazem (120 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Both agents
Number of subjects: 13
Study: 7318625

Group type: EXPERIMENTAL
Intervention: Infrared coagulation
Number of subjects: 0
Study: 31493397

Group type: EXPERIMENTAL
Intervention: Mirikizumab 50 mg
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Mirikizumab 200 mg
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Mirikizumab 600 mg
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Subcutaneous mirikizumab 200 mg every 4 weeks
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Subcutaneous mirikizumab 200 mg every 12 weeks
Number of subjects: 249
Study: 28974849

Group type: EXPERIMENTAL
Intervention: Unilateral spinal anesthesia (Group S)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Epidural anesthesia (Group E)
Number of subjects: 120
Study: 26084944

Group type: EXPERIMENTAL
Intervention: Intraocular lens treatment
Number of subjects: 104

Group type: COMPARATOR
Intervention: Contact lens treatment
Number of subjects: 104
Study: 24314875

Group type: EXPERIMENTAL
Intervention: RESMENA diet
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 55
Study: 21955403

Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg/day plus rosiglitazone 4 mg/day
Number of subjects: 53

Group type: COMPARATOR
Intervention: simvastatin 40 mg/day plus placebo
Number of subjects: 53
Study: 19508722

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: ASA
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: ASA and clopidogrel combined
Number of subjects: 29
Study: 17125998

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.75 microg/mL with bupivacaine
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.75 microg/mL with ropivacaine
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.75 microg/mL with levobupivacaine
Number of subjects: 171

Group type: COMPARATOR
Intervention: Bupivacaine alone
Number of subjects: 171

Group type: COMPARATOR
Intervention: Ropivacaine alone
Number of subjects: 171

Group type: COMPARATOR
Intervention: Levobupivacaine alone
Number of subjects: 171
Study: 15894238

Group type: EXPERIMENTAL
Intervention: Hand-carried cardiac ultrasound (HCU)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Full-featured standard echo (FE) system
Number of subjects: 150
Study: 12243634

Group type: EXPERIMENTAL
Intervention: Mild Cognitive Impairment (MCI)
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: Dementia
Number of subjects: 682

Group type: COMPARATOR
Intervention: Alzheimer-type dementia
Number of subjects: 682
Study: 9797234

Group type: EXPERIMENTAL
Intervention: Imipenem-cilastatin (0.5 g four times a day)
Number of subjects: 371

Group type: COMPARATOR
Intervention: Piperacillin-tazobactam (4.5 g three times a day)
Number of subjects: 371
Study: 8457237

Group type: EXPERIMENTAL
Intervention: Methylprednisolone aceponate (MPA) 0.01%, 0.05%, 0.1%, 0.5% ointment
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Methylprednisolone aceponate (MPA) 0.1% (cream, ointment, fatty ointment)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Difluocortolone 21-valerate 0.1% (DFV) ointment
Number of subjects: 165

Group type: COMPARATOR
Intervention: Various corticosteroids (betamethasone 17,21-dipropionate 0.64%, betamethasone 17-valerate 0.1%, clobetasol 17-propionate 0.05%, hydrocortisone 17-butyrate 0.1%, prednicarbate 0.25%)
Number of subjects: 165
Study: 3784450

Group type: EXPERIMENTAL
Intervention: Middle-molecular hydroxyethyl starch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextran 40
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isotonic saline solution
Number of subjects: 0
Study: 31372210

Group type: EXPERIMENTAL
Intervention: Diode Laser (DL)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional Endodontic Treatment (Endo)
Number of subjects: 56
Study: 29901374

Group type: EXPERIMENTAL
Intervention: Vaginal conjugated equine estrogen (CEE) cream 0.5 g once a week
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 40
Study: 25179753

Group type: EXPERIMENTAL
Intervention: Brief Intervention with Telephone Boosters (BI-B)
Number of subjects: 1285

Group type: EXPERIMENTAL
Intervention: Screening, Assessment, and Referral to Treatment (SAR)
Number of subjects: 1285

Group type: COMPARATOR
Intervention: Minimal Screening Only (MSO)
Number of subjects: 1285
Study: 22907053

Group type: EXPERIMENTAL
Intervention: Ventilatory response to hypoxia in men
Number of subjects: 4675

Group type: EXPERIMENTAL
Intervention: Desaturation response to hypoxia in men
Number of subjects: 4675

Group type: EXPERIMENTAL
Intervention: Cardiac response to hypoxia
Number of subjects: 4675

Group type: EXPERIMENTAL
Intervention: Desaturation response at exercise in trained subjects
Number of subjects: 4675

Group type: EXPERIMENTAL
Intervention: Cardiac response in post-menopausal women
Number of subjects: 4675
Study: 20041428

Group type: EXPERIMENTAL
Intervention: Topical (0.5%) Pycnogenol and oral Pycnogenol
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Oral and topical Pycnogenol
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Pycnogenol (oral and topical)
Number of subjects: 84
Study: 18318105

Group type: EXPERIMENTAL
Intervention: Stabilisation exercise training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 22
Study: 16362714

Group type: EXPERIMENTAL
Intervention: Zolmitriptan nasal spray
Number of subjects: 851
Study: 12222660

Group type: EXPERIMENTAL
Intervention: PYCNOGENOL chewing gums (5 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control gums without PYCNOGENOL
Number of subjects: 40
Study: 10381531

Group type: EXPERIMENTAL
Intervention: SCF + G-CSF
Number of subjects: 203

Group type: COMPARATOR
Intervention: G-CSF
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: G-CSF + SCF
Number of subjects: 203
Study: 7721419

Group type: EXPERIMENTAL
Intervention: cilazapril
Number of subjects: 17

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 17
Study: 10145317

Group type: EXPERIMENTAL
Intervention: One hand ventilation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Two hands ventilation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Small hands
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Medium hands
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Large hands
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Gloves
Number of subjects: 24

Group type: COMPARATOR
Intervention: No gloves
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Code Blue resuscitator
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hospitak resuscitator
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pulmanex resuscitator
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mercury resuscitator
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ambu SPUR resuscitator
Number of subjects: 24
Study: 6113174

Group type: EXPERIMENTAL
Intervention: Ketazolam
Number of subjects: 95

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 95
Study: 30701655

Group type: EXPERIMENTAL
Intervention: Treatment stimulation (peripheral nerve stimulation)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 77
Study: 28210811

Group type: EXPERIMENTAL
Intervention: Oral health care training (IG)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Non-intervention group (non-IG)
Number of subjects: 81

Group type: COMPARATOR
Intervention: DC group (control)
Number of subjects: 81
Study: 25471234

Group type: EXPERIMENTAL
Intervention: ARB plus CCB therapy (olmesartan 20 mg per day)
Number of subjects: 1078

Group type: COMPARATOR
Intervention: High-dose ARB therapy (olmesartan 40 mg per day)
Number of subjects: 1078
Study: 23589779

Group type: EXPERIMENTAL
Intervention: Tolterodine (2 mg) + Desmopressin (20 μg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Desmopressin (20 μg) + placebo
Number of subjects: 100
Study: 21403136

Group type: EXPERIMENTAL
Intervention: Bulb syringe self-irrigation with ear drops and instructions
Number of subjects: 237

Group type: COMPARATOR
Intervention: Routine care (ear drops followed by clinic irrigation)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Bulb syringe self-irrigation
Number of subjects: 237

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 237
Study: 19522897

Group type: EXPERIMENTAL
Intervention: Shellac F
Number of subjects: 10

Group type: COMPARATOR
Intervention: Duraphat
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isodan
Number of subjects: 10
Study: 19122245

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery (CABG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aggressive management including early revascularization and potent platelet inhibition
Number of subjects: 0
Study: 15238022

Group type: EXPERIMENTAL
Intervention: Standard condition requiring study for a later memory test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Condition requiring a judgment about unusual letters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-frequency words (LF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-frequency words (HF)
Number of subjects: 0
Study: 11985186

Group type: EXPERIMENTAL
Intervention: 20-minute music-based intervention in a preoperative holding area
Number of subjects: 20

Group type: COMPARATOR
Intervention: Customary preoperative care
Number of subjects: 20
Study: 9779099

Group type: EXPERIMENTAL
Intervention: Etched (phosphoric acid gel)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bonded (Scotchbond MP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Smeared (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cementation with zinc phosphate cement at 100N
Number of subjects: 30
Study: 7768655

Group type: EXPERIMENTAL
Intervention: 3 weeks immobilisation in a plaster splint
Number of subjects: 33

Group type: COMPARATOR
Intervention: 5 weeks immobilisation in a plaster splint
Number of subjects: 33
Study: 2698272

Group type: EXPERIMENTAL
Intervention: Amineptine (100-200 mg per day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Imipramine (50-100 mg per day)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Amineptine
Number of subjects: 33

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 33
Study: 776441

Group type: EXPERIMENTAL
Intervention: Guanethidine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Reserpine
Number of subjects: 49
Study: 31084971

Group type: EXPERIMENTAL
Intervention: Intraoperative ketamine infusion at a rate of 6 mcg/kg/min for 75 minutes
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Intraoperative ketamine infusion
Number of subjects: 91

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 91
Study: 27823944

Group type: EXPERIMENTAL
Intervention: Cervical lidocaine-prilocaine (LP) cream
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 26123101

Group type: EXPERIMENTAL
Intervention: Bovine milk containing antibodies
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 23731768

Group type: EXPERIMENTAL
Intervention: AZD3199 (200, 400 or 800 μg o.d.)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Formoterol (9 μg b.i.d.)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 329
Study: 21411606

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (20,000 IU for < 12 mo; 45,000 IU for ≥ 12 mo)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 19268410

Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.1 to 0.2 mg/kg/d)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cyclosporine (5 to 6 mg/kg/d)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 41
Study: 17879570

Group type: EXPERIMENTAL
Intervention: 200 U BTX‐A injected endoscopically into the antrum and the distal gastric body
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.9% Saline injected endoscopically into the antrum and the distal gastric body
Number of subjects: 10
Study: 16036031

Group type: EXPERIMENTAL
Intervention: Drugs that modulate the renin-angiotensin and sympathetic nervous systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Redirected therapy to prevent and treat sudden death
Number of subjects: 0
Study: 11598428

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Behavior Therapy (BT)
Number of subjects: 65
Study: 9477980

Group type: COMPARATOR
Intervention: Deferral of photocoagulation in eyes assigned to the Early Treatment Diabetic Retinopathy Study (ETDRS)
Number of subjects: 0
Study: 8163257

Group type: EXPERIMENTAL
Intervention: Topical felbinac
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piroxicam
Number of subjects: 0
Study: 3673206

Group type: EXPERIMENTAL
Intervention: 5 micrograms of Pasteur's hepatitis B vaccine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 2 micrograms of Pasteur's hepatitis B vaccine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 1 microgram of Pasteur's hepatitis B vaccine
Number of subjects: 300
Study: 30686266

Group type: EXPERIMENTAL
Intervention: Lactobacillus buchneri strains (56.1, 56.4, 56.9, 56.26, and commercial inoculant 'Lalsil Cana')
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (without inoculation)
Number of subjects: 4
Study: 29092761

Group type: EXPERIMENTAL
Intervention: Nurse-driven targeted HIV screening alongside physician-directed diagnostic testing
Number of subjects: 148327

Group type: COMPARATOR
Intervention: Diagnostic testing alone
Number of subjects: 148327
Study: 27369430

Group type: EXPERIMENTAL
Intervention: Amoxicillin (first taste)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Amoxicillin (second taste)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Clindamycin Rising
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Clindamycin Perrigo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Clindamycin Greenstone
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Acetaminophen elixir
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Acetaminophen suspension
Number of subjects: 46
Study: 26273191

Group type: EXPERIMENTAL
Intervention: Torasemide-PR 10 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Furosemide-IR 40 mg
Number of subjects: 10
Study: 23207882

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resistance training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 21669380

Group type: EXPERIMENTAL
Intervention: Higher hemoglobin (Hgb) levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loss of 2 g/dl Hgb or more
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower levels of Hgb
Number of subjects: 0
Study: 19358959

Group type: EXPERIMENTAL
Intervention: Usual care plus adjunctive care by a homeopath
Number of subjects: 47

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 47
Study: 16473984

Group type: EXPERIMENTAL
Intervention: Citalopram + Methylphenidate (CIT + MPH)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Citalopram + Placebo (CIT + PBO)
Number of subjects: 16
Study: 12740264

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (80 micro g/4.5 micro g, bid)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Budesonide (200 micro g, bid)
Number of subjects: 467
Study: 10692524

Group type: EXPERIMENTAL
Intervention: Cuprammonium (CU) dialyser
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cuprammonium (CU) dialyser with dialysate filter (CUf)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Polysulphon (PS) dialyser
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cuprammonium (CU) and CUf
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cuprammonium (CU)
Number of subjects: 11
Study: 9179687

Group type: EXPERIMENTAL
Intervention: Preoperative endocrine therapy (leuprolide and chlormadinone for 3 months)
Number of subjects: 224
Study: 1422972

Group type: EXPERIMENTAL
Intervention: Oral phosphate 1500 mg/day
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Oral phosphate 2250 mg/day
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Oral phosphate 750 mg/day
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 3972658

Group type: EXPERIMENTAL
Intervention: 252Cf implants alone (Group I)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 252Cf implants in combination with external radiation (Group II)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Interstitial implants for recurrent or residual tumors (Group III)
Number of subjects: 47
Study: 31737925

Group type: EXPERIMENTAL
Intervention: Group A - Patients explained the importance of frequency volume charts by a doctor and then a nurse explained how to fill it.
Number of subjects: 137

Group type: COMPARATOR
Intervention: Group B - Patients were only explained how to fill it.
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Group A - Patients explained the importance of frequency volume charts.
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Patients aged 60's years old (vs 50's years).
Number of subjects: 137
Study: 30777509

Group type: EXPERIMENTAL
Intervention: Task switching during encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task switching with bivalent material (Experiment 2)
Number of subjects: 0
Study: 30305170

Group type: EXPERIMENTAL
Intervention: High media multitaskers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relevant environmental cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: Irrelevant cue condition
Number of subjects: 0
Study: 27061508

Group type: EXPERIMENTAL
Intervention: SOLE VLBWI Questionnaire
Number of subjects: 152

Group type: COMPARATOR
Intervention: PedsQL
Number of subjects: 152